Matthew Pompili

Title: The Innovations of Matthew Pompili

Introduction

Matthew Pompili is an accomplished inventor based in Toronto, Canada. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on nilotinib hydrochloride. His dedication to research and development has led to the creation of a unique solid form of this compound.

Latest Patents

Matthew holds a patent for a solid form of nilotinib hydrochloride. This patent describes a co-crystal of nilotinib hydrochloride and levulinic acid, which exists in a molar ratio of 1:2. The process for the preparation of this co-crystal is also detailed in his patent, showcasing his expertise in pharmaceutical formulations.

Career Highlights

Matthew Pompili is currently employed at Apotex Inc., a leading pharmaceutical company known for its commitment to quality and innovation. His work at Apotex has allowed him to focus on developing new and effective drug formulations that can benefit patients worldwide.

Collaborations

Throughout his career, Matthew has collaborated with notable colleagues, including David A. Stradiotto and Probal Kanti Datta. These collaborations have enriched his research and contributed to the advancement of pharmaceutical sciences.

Conclusion

Matthew Pompili's innovative work in the field of pharmaceuticals, particularly with his patent on nilotinib hydrochloride, highlights his significant contributions to the industry. His collaborations and career at Apotex Inc. further emphasize his role as a key player in advancing pharmaceutical research.